Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Actavis Laboratories FL, Inc.
FDA Inspection
•Actavis Laboratories FL, Inc.•July 19, 2018

Actavis Laboratories FL, Inc. – FDA Inspection, Jul 19, 2018

Record Details

This FDA Inspection record concerns Actavis Laboratories FL, Inc., with an inspection on July 19, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Actavis Laboratories FL, Inc.
Inspection Date
July 19, 2018
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Chiaochun J. Wang (Issuing Officer)
  • Fabian N. Chaparro-rodriguez (Issuing Officer)
  • Ileana Barreto-Pettit (Issuing Officer)
  • Jennifer L. Huntington (FDA Associated Person)
View Company Profile

ID · 3f37bb61-9c39-496d-b2dc-e5d4e71db4a5

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1059371
FDA center
Human Drugs
Project area
Generic Drug Evaluation
Outcome
Form 483 issued
Enforcement
Warning Letter

FDA Citations

10
  1. 21 CFR 211.100(a)Absence of Written Procedures
  2. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  3. 21 CFR 211.160(b)(4)Written calibration procedures
  4. 21 CFR 211.192Investigations of discrepancies, failures
  5. 21 CFR 211.22(d)Procedures not in writing, fully followed
  6. 21 CFR 211.25(a)Training , Education , Experience overall
  7. 21 CFR 211.25(c)Inadequate number of personnel
  8. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  9. 21 CFR 211.68(a)Calibration/Inspection/Checking not done
  10. 21 CFR 211.68(b)Computer control of master formula records

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Actavis Laboratories FL, Inc.

8
DateClassificationOfficeProject area
November 18, 2025VAIFlorida District OfficeDrug Quality Assurance
May 25, 2021VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 17, 2020OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 28, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 15, 2016VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 8 other inspections on the company page
Other documents for Actavis Laboratories FL, Inc.
  • FDA Inspection 1287706 - 2025-11-18
  • FDA Inspection 1142532 - 2021-05-25
  • FDA Inspection 1115283 - 2020-01-17
  • FDA Inspection 1033875 - 2017-11-28
  • FDA Inspection 957124 - 2016-01-15

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Actavis Laboratories FL, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.